Autolus Therapeutics Cash from Financing (TTM) Analysis

Autolus Therapeutics PLC (AUTL)

4.07 -0.12 (-2.86%) USD | NASDAQ | May 06, 16:00

4.085 +0.02 (+0.37%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	-0.883M
September 30, 2023	222.60M
June 30, 2023	222.70M
March 31, 2023	222.92M
December 31, 2022	223.61M
September 30, 2022	147.52M
June 30, 2022	147.18M
March 31, 2022	160.74M
December 31, 2021	284.06M

Date	Value
September 30, 2021	137.04M
June 30, 2021	137.28M
March 31, 2021	123.43M
December 31, 2020	74.42M
September 30, 2020	74.06M
June 30, 2020	73.47M
March 31, 2020	183.17M
December 31, 2019	108.86M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.883M

Minimum

Dec 2023

284.06M

Maximum

Dec 2021

149.54M

Average

147.18M

Median

Jun 2022

Cash from Financing (TTM) Benchmarks